{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:27Z","timestamp":1790957547503,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":7890,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1998]]},"DOI":"10.1254\/jjp.77.61","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T16:32:11Z","timestamp":1030379531000},"page":"61-70","source":"Crossref","is-referenced-by-count":21,"title":["Vascular \u03b11-Adrenoceptor Subtype Selectivity and \u03b11-Blocker-Induced Orthostatic Hypotension"],"prefix":"10.1016","volume":"77","author":[{"given":"Hitoshi","family":"Take","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Awaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ikegaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozoh","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.77.61_bib1","first-page":"267","article-title":"International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update","volume":"47","author":"Hieble","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.77.61_bib2","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.85.19.7159","article-title":"Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor","volume":"85","author":"Cotecchia","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.77.61_bib3","first-page":"876","article-title":"Solution-phase library screening for the identification of rare clones: isolation of an alpha ID-adrenergic receptor cDNA","volume":"40","author":"Perez","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1006\/bbrc.1993.2130","article-title":"Cloning, functional expression and tissue distribution of human cDNA for the alpha lC-adrenergic receptor","volume":"195","author":"Hirasawa","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.77.61_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0014-5793(95)00330-C","article-title":"Cloning, functional expression and tissue distribution of human alpha lC-adrenoceptor splice variants","volume":"363","author":"Hirasawa","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1254\/jjp.77.61_bib6","first-page":"221","article-title":"Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification","volume":"46","author":"Price","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib7","first-page":"171","article-title":"Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology","volume":"45","author":"Price","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib8","first-page":"87","article-title":"Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+","volume":"40","author":"Minneman","year":"1988","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.77.61_bib9","first-page":"166","article-title":"Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha la) that couples with Ca2+ influx","volume":"36","author":"Tsujimoto","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib10","first-page":"30","article-title":"Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle","volume":"46","author":"Piascik","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1476-5381.1995.tb15907.x","article-title":"Characterization of an alpha 1 D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline","volume":"115","author":"Kenny","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.77.61_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0024-3205(95)02079-X","article-title":"The alpha 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta","volume":"57","author":"Testa","year":"1995","journal-title":"Life Sci"},{"key":"10.1254\/jjp.77.61_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jama.1991.03470030094030","article-title":"Alpha-blocker therapy of hypertension. An unfulfilled promise","volume":"266","author":"Khoury","year":"1991","journal-title":"Jama"},{"key":"10.1254\/jjp.77.61_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2165\/00002018-199411010-00003","article-title":"Adverse effects of alpha 1-adrenergic blocking drugs","volume":"11","author":"Carruthers","year":"1994","journal-title":"Drug Safety"},{"key":"10.1254\/jjp.77.61_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00171338","article-title":"Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor","volume":"348","author":"Michel","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1254\/jjp.77.61_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00005344-199212000-00023","article-title":"Naftopidil, a new adrenoceptor blocking agent with Ca2+antagonistic properties: interaction with adrenoceptors","volume":"20","author":"Sponer","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1254\/jjp.77.61_bib17","first-page":"C43","article-title":"Differential effects of naftopidil and prazosin on the hemodynamic responses to passive upright tilt in healthy normotensives","volume":"346","author":"de May","year":"1992","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1254\/jjp.77.61_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/pgmj.70.823.363","article-title":"Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction","volume":"70","author":"Farthing","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1254\/jjp.77.61_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0160-5402(82)90055-9","article-title":"A rat model for predicting orthostatic hypotension during acute and chronic antihypertensive drug therapy","volume":"7","author":"Humphrey","year":"1982","journal-title":"J Pharmacol Methods"},{"key":"10.1254\/jjp.77.61_bib20","first-page":"155","article-title":"Reversal of antihypertensive agent-induced postural hypotension with physostigmine","volume":"311","author":"Park","year":"1991","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1254\/jjp.77.61_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1254\/jjp.55.391","article-title":"Pharmacological profile of the novel alpha-adrenoceptor antagonist KT-611 (naftopidil)","volume":"55","author":"Muramatsu","year":"1991","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.77.61_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1254\/jjp.77.61_bib23","first-page":"2769","article-title":"Identification of alpha lC-adrenergic receptor mRNA in bovine retinal pigment epithelium","volume":"34","author":"Horie","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1254\/jjp.77.61_bib24","first-page":"823","article-title":"Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha lC-adrenergic receptor provide evidence for its classification as the alpha 1A subtype","volume":"46","author":"Perez","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.77.61_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/nar\/18.4.1053","article-title":"Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor","volume":"18","author":"Voigt","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1254\/jjp.77.61_bib26","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/nar\/13.5.1431","article-title":"Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family","volume":"13","author":"Fort","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"10.1254\/jjp.77.61_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0922-4106(94)90065-5","article-title":"The pharmacological profile of cloned and stably expressed alpha lb-adrenoceptor in CHO cells","volume":"268","author":"Horie","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.77.61_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","article-title":"LIGAND: a versatile computerized approach for characterization of ligand-binding systems","volume":"107","author":"Munson","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1254\/jjp.77.61_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-5347(17)39620-9","article-title":"Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group","volume":"144","author":"Kawabe","year":"1990","journal-title":"J Urol"},{"key":"10.1254\/jjp.77.61_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0922-4106(95)90195-7","article-title":"Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy","volume":"288","author":"Foglar","year":"1995","journal-title":"Eur J Pharmacol"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819311473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819311473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjp\/77\/1\/77_1_61\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:27:07Z","timestamp":1605637627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819311473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998]]}},"alternative-id":["S0021519819311473"],"URL":"https:\/\/doi.org\/10.1254\/jjp.77.61","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}